Cargando…
Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease
Anal cancer is a major health problem. This study seeks to determine if the topical protease inhibitor Saquinavir (SQV), is effective at the prevention of anal cancer in transgenic mice with established anal dysplasia. K14E6/E7 mice were entered into the study when the majority spontaneously develop...
Autores principales: | Gunder, Laura C., Johnson, Hillary R., Yao, Evan, Moyer, Tyra H., Green, Heather A., Sherer, Nathan, Zhang, Wei, Carchman, Evie H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146494/ https://www.ncbi.nlm.nih.gov/pubmed/37112993 http://dx.doi.org/10.3390/v15041013 |
Ejemplares similares
-
Systemic Delivery of a Dual PI3K/mTOR Inhibitor More Effective than Topical Delivery in Preventing Anal Carcinogenesis in an HPV Transgenic Mouse Model
por: Gunder, Laura C, et al.
Publicado: (2022) -
Dysregulation of Autophagy Contributes to Anal Carcinogenesis
por: Carchman, Evie H., et al.
Publicado: (2016) -
Genetic inhibition of autophagy in a transgenic mouse model of anal cancer
por: Rademacher, Brooks L., et al.
Publicado: (2018) -
Inhibition of mTOR Reduces Anal Carcinogenesis in Transgenic Mouse Model
por: Sun, Zhi-Jun, et al.
Publicado: (2013) -
HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins
por: Park, Soyeong, et al.
Publicado: (2021)